Aveo Pharmaceuticals, Biogen Idec deal

Aveo received a $5 million milestone payment from Biogen Idec under a 2009 deal granting Biogen Idec an option to develop and commercialize antibodies targeting EGFR 3 ( HER3, ErbB3) outside of Nort...